The Safetyof Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation

The safety and optimal strategy of the use of dabigatran versus uninterrupted warfarin in atrial fibrillation ablation is currently unclear. We performed a retrospective analysis between July 2011-October 2012 of all patients undergoing an AF ablation who received uninterrupted warfarin therapy (199...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Atr Fibrillation
Glavni autori: Garcia, Luis I, Mascarenhas, Mark A, Ahuja, Kartikya, Aizer, Anthony, Bernstein, Neil, Bernstein, Scott A, Fowler, Steve J, Holmes, Douglas S, Park, David S, Chinitz, Larry
Format: Artigo
Jezik:Inglês
Izdano: Cardiofront, Inc 2014
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956124/
https://ncbi.nlm.nih.gov/pubmed/27957036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.965
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items